View in EDS PDF Full Text

CONSENSO ARGENTINO INTERSOCIEDADES DE INFECCIÓN URINARIA 2018-2019 - PARTE II.

Saved in:
Bibliographic Details
Title: CONSENSO ARGENTINO INTERSOCIEDADES DE INFECCIÓN URINARIA 2018-2019 - PARTE II.
Alternate Title: Argentine Intersociety Consensus on Urinary Infection 2018-2019 - Part II.
Authors: NEMIROVSKY, CORINA1 corina.nemirovsky@hospitalitaliano.org.ar, LÓPEZ FURST, MARÍA JOSÉ1, PRYLUKA, DANIEL1, DE VEDIA, LAUTARO1, SCAPELLATO, PABLO1, COLQUE, ANGEL1, BARCELONA, LAURA1, DESSE, JAVIER1, CARADONTI, MATÍAS2, VARCASIA, DANIEL2, IPOHORSKI, GABRIEL3, VOTTA, ROBERTO4, ZYLBERMAN, MARCELO5, ROMANI, ADRIANA5, VALDEZ, PASCUAL5, AMALFA, FLAVIA6, LUCERO, CELESTE7, FERNÁNDEZ LAUSI, ADRIANA1, FERNÁNDEZ GARCES, ALEJANDRO1, RODRÍGUEZ, CLAUDIA1
Source: Revista Medicina. May/Jun2020, Vol. 80 Issue 3, p241-247. 7p.
Abstract (English): The second part of the Inter-Society Argentine Consensus on Urinary Tract Infection (UTI) includes the analysis of special situations. In patients with urinary catheter, urine culture should be requested only in the presence of UTI symptomatology, before instrumentation of the urinary tract, or as a post-transplant control. The antibiotics recommended for empirical treatment in patients without risk factors are third-generation cephalosporins or aminoglycosides. UTIs associated with stones are always considered complicated. In case of obstruction with urosepsis, an emergency drainage should be performed via a percutaneous nefrostomy or ureteral stenting. In patients with stents or ureteral prostheses, such as double J catheters, empirical treatment should be based on epidemiology, prior antibiotics, and clinical status. Before the extracorporeal lithotripsy procedure, bacteriuria should be investigated and antibiotic prophylaxis should be administered in case of positive result, according to the antibiogram. First generation cephalosporins or aminoglycosides are valid alternatives. The use of antibiotic prophylaxis with first-generation cephalosporins or aminoglycosides before percutaneous nephrolithotomy is recommended. Transrectal prostatic biopsy can be associated with infectious complications, such as UTI or acute prostatitis, mainly due to Escherichia coli or other enterobacteria. In patients without risk factors for multiresistant bacteria and negative urine culture, prophylaxis with intravenous amikacin or ceftriaxone is recommended. In patients with positive urine culture, prophylaxis will be performed according to the antibiogram, from 24 hours before to 24 hours post-procedure. For the targeted treatment of post-transrectal biopsy prostatitis, carbapenems for 3-4 weeks are the treatment of choice. [ABSTRACT FROM AUTHOR]
Abstract (Spanish): La segunda parte del Consenso Argentino Intersociedades de Infección Urinaria incluye el análisis de situaciones especiales. En pacientes con sonda vesical se debe solicitar urocultivo solo cuando hay signo-sintomatología de infección del tracto urinario, antes de instrumentaciones de la vía urinaria o como control en pacientes post-trasplante renal. El tratamiento empírico recomendado en pacientes sin factores de riesgo es cefalosporinas de tercera generación o aminoglucósidos. Las infecciones del tracto urinario asociadas a cálculos son siempre consideradas complicadas. En caso de obstrucción con urosepsis, deberá realizarse drenaje de urgencia por vía percutánea o ureteral. En pacientes con stents o prótesis ureterales, como catéteres doble J, el tratamiento empírico deberá basarse en la epidemiología, los antibióticos previos y el estado clínico. Antes del procedimiento de litotricia extracorpórea se recomienda pesquisar la bacteriuria y, si es positiva, administrar profilaxis antibiótica según el antibiograma. Cefalosporinas de primera generación o aminoglúcosidos son opciones válidas. Se recomienda aplicar profilaxis antibiótica con cefalosporinas de primera generación o aminoglúcosidos antes de la nefrolitotomía percutánea. La biopsia prostática trans-rectal puede asociarse a complicaciones infecciosas, como infecciones del tracto urinario o prostatitis aguda, principalmente por Escherichia coli u otras enterobacterias. En pacientes sin factores de riesgo para gérmenes multirresistentes y urocultivo negativo se recomienda realizar profilaxis con amikacina o ceftriaxona endovenosas. En pacientes con urocultivo positivo, se realizará profilaxis según antibiograma, 24 horas previas a 24 horas post-procedimiento. Para el tratamiento dirigido de la prostatitis post-biopsia trans-rectal, los carbapenémicos durante 3-4 semanas son el tratamiento de elección. [ABSTRACT FROM AUTHOR]
Copyright of Revista Medicina is the property of Revista Medicina and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: MedicLatina
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: lth
DbLabel: MedicLatina
An: 157060815
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CONSENSO ARGENTINO INTERSOCIEDADES DE INFECCIÓN URINARIA 2018-2019 - PARTE II.
– Name: TitleAlt
  Label: Alternate Title
  Group: TiAlt
  Data: Argentine Intersociety Consensus on Urinary Infection 2018-2019 - Part II.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22NEMIROVSKY%2C+CORINA%22">NEMIROVSKY, CORINA</searchLink><relatesTo>1</relatesTo><i> corina.nemirovsky@hospitalitaliano.org.ar</i><br /><searchLink fieldCode="AR" term="%22LÓPEZ+FURST%2C+MARÍA+JOSÉ%22">LÓPEZ FURST, MARÍA JOSÉ</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22PRYLUKA%2C+DANIEL%22">PRYLUKA, DANIEL</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22DE+VEDIA%2C+LAUTARO%22">DE VEDIA, LAUTARO</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22SCAPELLATO%2C+PABLO%22">SCAPELLATO, PABLO</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22COLQUE%2C+ANGEL%22">COLQUE, ANGEL</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22BARCELONA%2C+LAURA%22">BARCELONA, LAURA</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22DESSE%2C+JAVIER%22">DESSE, JAVIER</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22CARADONTI%2C+MATÍAS%22">CARADONTI, MATÍAS</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22VARCASIA%2C+DANIEL%22">VARCASIA, DANIEL</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22IPOHORSKI%2C+GABRIEL%22">IPOHORSKI, GABRIEL</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22VOTTA%2C+ROBERTO%22">VOTTA, ROBERTO</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22ZYLBERMAN%2C+MARCELO%22">ZYLBERMAN, MARCELO</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22ROMANI%2C+ADRIANA%22">ROMANI, ADRIANA</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22VALDEZ%2C+PASCUAL%22">VALDEZ, PASCUAL</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22AMALFA%2C+FLAVIA%22">AMALFA, FLAVIA</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22LUCERO%2C+CELESTE%22">LUCERO, CELESTE</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22FERNÁNDEZ+LAUSI%2C+ADRIANA%22">FERNÁNDEZ LAUSI, ADRIANA</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22FERNÁNDEZ+GARCES%2C+ALEJANDRO%22">FERNÁNDEZ GARCES, ALEJANDRO</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22RODRÍGUEZ%2C+CLAUDIA%22">RODRÍGUEZ, CLAUDIA</searchLink><relatesTo>1</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Revista+Medicina%22">Revista Medicina</searchLink>. May/Jun2020, Vol. 80 Issue 3, p241-247. 7p.
– Name: Abstract
  Label: Abstract (English)
  Group: Ab
  Data: The second part of the Inter-Society Argentine Consensus on Urinary Tract Infection (UTI) includes the analysis of special situations. In patients with urinary catheter, urine culture should be requested only in the presence of UTI symptomatology, before instrumentation of the urinary tract, or as a post-transplant control. The antibiotics recommended for empirical treatment in patients without risk factors are third-generation cephalosporins or aminoglycosides. UTIs associated with stones are always considered complicated. In case of obstruction with urosepsis, an emergency drainage should be performed via a percutaneous nefrostomy or ureteral stenting. In patients with stents or ureteral prostheses, such as double J catheters, empirical treatment should be based on epidemiology, prior antibiotics, and clinical status. Before the extracorporeal lithotripsy procedure, bacteriuria should be investigated and antibiotic prophylaxis should be administered in case of positive result, according to the antibiogram. First generation cephalosporins or aminoglycosides are valid alternatives. The use of antibiotic prophylaxis with first-generation cephalosporins or aminoglycosides before percutaneous nephrolithotomy is recommended. Transrectal prostatic biopsy can be associated with infectious complications, such as UTI or acute prostatitis, mainly due to Escherichia coli or other enterobacteria. In patients without risk factors for multiresistant bacteria and negative urine culture, prophylaxis with intravenous amikacin or ceftriaxone is recommended. In patients with positive urine culture, prophylaxis will be performed according to the antibiogram, from 24 hours before to 24 hours post-procedure. For the targeted treatment of post-transrectal biopsy prostatitis, carbapenems for 3-4 weeks are the treatment of choice. [ABSTRACT FROM AUTHOR]
– Name: Abstract
  Label: Abstract (Spanish)
  Group: Ab
  Data: La segunda parte del Consenso Argentino Intersociedades de Infección Urinaria incluye el análisis de situaciones especiales. En pacientes con sonda vesical se debe solicitar urocultivo solo cuando hay signo-sintomatología de infección del tracto urinario, antes de instrumentaciones de la vía urinaria o como control en pacientes post-trasplante renal. El tratamiento empírico recomendado en pacientes sin factores de riesgo es cefalosporinas de tercera generación o aminoglucósidos. Las infecciones del tracto urinario asociadas a cálculos son siempre consideradas complicadas. En caso de obstrucción con urosepsis, deberá realizarse drenaje de urgencia por vía percutánea o ureteral. En pacientes con stents o prótesis ureterales, como catéteres doble J, el tratamiento empírico deberá basarse en la epidemiología, los antibióticos previos y el estado clínico. Antes del procedimiento de litotricia extracorpórea se recomienda pesquisar la bacteriuria y, si es positiva, administrar profilaxis antibiótica según el antibiograma. Cefalosporinas de primera generación o aminoglúcosidos son opciones válidas. Se recomienda aplicar profilaxis antibiótica con cefalosporinas de primera generación o aminoglúcosidos antes de la nefrolitotomía percutánea. La biopsia prostática trans-rectal puede asociarse a complicaciones infecciosas, como infecciones del tracto urinario o prostatitis aguda, principalmente por Escherichia coli u otras enterobacterias. En pacientes sin factores de riesgo para gérmenes multirresistentes y urocultivo negativo se recomienda realizar profilaxis con amikacina o ceftriaxona endovenosas. En pacientes con urocultivo positivo, se realizará profilaxis según antibiograma, 24 horas previas a 24 horas post-procedimiento. Para el tratamiento dirigido de la prostatitis post-biopsia trans-rectal, los carbapenémicos durante 3-4 semanas son el tratamiento de elección. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Revista Medicina is the property of Revista Medicina and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=lth&AN=157060815
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: spa
        Text: Spanish
    PhysicalDescription:
      Pagination:
        PageCount: 7
        StartPage: 241
    Titles:
      – TitleFull: CONSENSO ARGENTINO INTERSOCIEDADES DE INFECCIÓN URINARIA 2018-2019 - PARTE II.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: NEMIROVSKY, CORINA
      – PersonEntity:
          Name:
            NameFull: LÓPEZ FURST, MARÍA JOSÉ
      – PersonEntity:
          Name:
            NameFull: PRYLUKA, DANIEL
      – PersonEntity:
          Name:
            NameFull: DE VEDIA, LAUTARO
      – PersonEntity:
          Name:
            NameFull: SCAPELLATO, PABLO
      – PersonEntity:
          Name:
            NameFull: COLQUE, ANGEL
      – PersonEntity:
          Name:
            NameFull: BARCELONA, LAURA
      – PersonEntity:
          Name:
            NameFull: DESSE, JAVIER
      – PersonEntity:
          Name:
            NameFull: CARADONTI, MATÍAS
      – PersonEntity:
          Name:
            NameFull: VARCASIA, DANIEL
      – PersonEntity:
          Name:
            NameFull: IPOHORSKI, GABRIEL
      – PersonEntity:
          Name:
            NameFull: VOTTA, ROBERTO
      – PersonEntity:
          Name:
            NameFull: ZYLBERMAN, MARCELO
      – PersonEntity:
          Name:
            NameFull: ROMANI, ADRIANA
      – PersonEntity:
          Name:
            NameFull: VALDEZ, PASCUAL
      – PersonEntity:
          Name:
            NameFull: AMALFA, FLAVIA
      – PersonEntity:
          Name:
            NameFull: LUCERO, CELESTE
      – PersonEntity:
          Name:
            NameFull: FERNÁNDEZ LAUSI, ADRIANA
      – PersonEntity:
          Name:
            NameFull: FERNÁNDEZ GARCES, ALEJANDRO
      – PersonEntity:
          Name:
            NameFull: RODRÍGUEZ, CLAUDIA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: May/Jun2020
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 13900218
          Numbering:
            – Type: volume
              Value: 80
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Revista Medicina
              Type: main
ResultId 1